SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.
Lancet. 2021 Jul 17;398(10296):262-276. doi: 10.1016/S0140-6736(21)00536-5. Epub 2021 Jun 30.
Lancet. 2021.
PMID: 34216571
Review.